首页> 外文OA文献 >Critique of ‘Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial’ ☆☆Critique of: Richard P. Dutton, Michael Parr, Bartholomew J. Tortella et al. Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial, The Journal of TRAUMA Injury, Infection, and Critical Care. Volume 71, Number 1, July 2011

【2h】

Critique of ‘Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial’ ☆☆Critique of: Richard P. Dutton, Michael Parr, Bartholomew J. Tortella et al. Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial, The Journal of TRAUMA Injury, Infection, and Critical Care. Volume 71, Number 1, July 2011

机译：“创伤患者中重组活化因子VII安全性的批判：对照试验的结果”☆☆批评：Richard p. Dutton，michael parr，Bartholomew J. Tortella等。创伤患者的重组活化因子VII安全性：对照试验，创伤损伤，感染和重症监护的结果。第71卷，第1期，2011年7月

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yassir S. Abdulrahman; Mazin A. Tuma; Husham Abdul Rahman; Ruben Peralta; Rifat Latifi;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Critique of ‘Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial' ☆Critique of: Richard P. Dutton, Michael Parr, Bartholomew J. Tortella et al. Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial, The Journal of TRAUMA Injury, Infection, and Critical Care. Volume 71, Number 1, July 2011 [J] . Husham Abdul Rahman, Mazin A. Tuma, Rifat Latifi, Journal of Emergency Medicine, Trauma and Acute Care . 2012,第2期

机译：批评“创伤患者中重组活化因子VII的安全性：来自对照试验的结果”☆批评：Richard P. Dutton，Michael Parr，Bartholomew J. Tortella等。创伤患者中重组活化的因子的安全性：对照试验，《创伤，损伤和重症护理杂志》的结果。 2011年7月第71卷第1期
2. Recombinant Activated Factor VII Safety in Trauma Patients: Results From the CONTROL Trial. [J] . Dutton RP, Tortella BJ, Bernard GR, The Journal of trauma . 2011,第1期

机译：创伤患者中重组活化的因子安全性：来自对照试验的结果。
3. Cost effectiveness of recombinant activated factor VII for the control of bleeding in patients with severe blunt trauma injuries in the United Kingdom. [J] . Morris S, Ridley S, Munro V, Anaesthesia: Journal of the Association of Anaesthetists of Great Britain and Ireland . 2007,第1期

机译：在英国，重组活化因子VII用于控制严重钝性外伤患者出血的成本效益。
4. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
5. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials [O] . Sandro B Rizoli, Kenneth D Boffard, Bruno Riou, 2006

机译：重组活化因子VII作为严重创伤性凝血病患者出血控制的辅助疗法：来自两项随机试验的亚组分析
6. Critique of ‘Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial’ ☆☆Critique of: Richard P. Dutton, Michael Parr, Bartholomew J. Tortella et al. Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial, The Journal of TRAUMA Injury, Infection, and Critical Care. Volume 71, Number 1, July 2011 [O] . Yassir S. Abdulrahman, Mazin A. Tuma, Husham Abdul Rahman, 2012

机译：“创伤患者中重组活化因子VII安全性的评价：对照试验的结果”☆☆批判：Richard p. Dutton，michael parr，Bartholomew J. Tortella等。创伤患者的重组活化因子VII安全性：对照试验，TRaUma损伤，感染和重症监护杂志的结果。第71卷，第1期，2011年7月
7. Prolonged Prothrombin Time After Recombinant Activated Factor VII Therapy in Critically Bleeding Trauma Patients Is Associated With Adverse Outcomes. [R] . McMullin, N. R., Wade, C. E., Holcomb, J. B., 2010

机译：重组活化因子VII治疗后严重出血创伤患者的凝血酶原时间延长与不良后果相关。

著录项

相似文献

相关主题

期刊订阅